Birger Jansson
Plus aucun poste en cours
Profil
Birger Jansson worked as Director of Research at Affibody AB, Vice President-Research & Development at CEPHEID, and Corporate VP-Research & Development at DiaSorin SpA from 2009 to 2011.
He holds a doctorate degree from the Royal Institute of Technology.
Anciens postes connus de Birger Jansson
| Sociétés | Poste | Fin |
|---|---|---|
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Directeur Technique/Scientifique/R&D | - |
| DIASORIN S.P.A. | Directeur Technique/Scientifique/R&D | - |
| CEPHEID | Directeur Technique/Scientifique/R&D | - |
Formation de Birger Jansson
| Royal Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DIASORIN S.P.A. | Health Technology |
| Entreprise privées | 2 |
|---|---|
CEPHEID
 CEPHEID Medical SpecialtiesHealth Technology CEPHEID develops, manufactures and markets fully-integrated systems that perform genetic analysis. The firm's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company was founded by Thomas L. Gutshall, William McMillan, Kurt Petersen, Greg Kovacs and M. Allen Northrup on March 4, 1996 and is headquartered in Sunnyvale, CA. | Health Technology |
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
